AstraZeneca R&D Boston
United States of America (USA)
1 November 2017 - 31 October 2018
Principal institution: AstraZeneca United States
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for AstraZeneca R&D Boston published between 1 November 2017 - 31 October 2018 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| AC | FC |
|---|---|
| 7 | 0.60 |
Outputs by subject (FC)
| Subject | AC | FC | |
|---|---|---|---|
| Life Sciences | 7 | 0.60 | |
Top articles by Altmetric score in current window
Developmental seizures and mortality result from reducing GABA receptor α2-subunit interaction with collybistin
Nature Communications
2018-08-07
Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells
Nature Cell Biology
2018-07-18
Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis
Nature Neuroscience
2018-07-26
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
